Voyager Therapeutics
Nasdaq VYGR · Lexington, MA
Works in Genetic & rare · Neurology · Psychiatry
Voyager Therapeutics is a clinical trial sponsor based in Lexington, MA, listed as Nasdaq VYGR. It has 2 active clinical trials with 70 planned participants, in Genetic & rare, Neurology and Psychiatry. Since 2021 it has completed 0 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq VYGR
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Voyager Therapeutics
Voyager Therapeutics is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 70 planned participants, in Genetic & rare, Neurology, Psychiatry. Since 2021 it has completed 0 trials and stopped 1 early.
Voyager Therapeutics is based in Lexington, MA and is listed as Nasdaq VYGR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Voyager Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-04.
Approve Suite is not affiliated with Voyager Therapeutics.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.